Free Trial
NASDAQ:UTMD

Utah Medical Products (UTMD) Stock Price, News & Analysis

Utah Medical Products logo
$56.34 +0.42 (+0.74%)
As of 02:52 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Utah Medical Products Stock (NASDAQ:UTMD)

Key Stats

Today's Range
$55.60
$56.78
50-Day Range
$53.32
$58.31
52-Week Range
$51.26
$77.33
Volume
8,159 shs
Average Volume
19,550 shs
Market Capitalization
$183.01 million
P/E Ratio
14.91
Dividend Yield
2.17%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Utah Medical Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

UTMD MarketRank™: 

Utah Medical Products scored higher than 45% of companies evaluated by MarketBeat, and ranked 640th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Utah Medical Products.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Utah Medical Products is 14.91, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.68.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Utah Medical Products is 14.91, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.63.

  • Price to Book Value per Share Ratio

    Utah Medical Products has a P/B Ratio of 1.63. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Utah Medical Products' valuation and earnings.
  • Percentage of Shares Shorted

    12.61% of the float of Utah Medical Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Utah Medical Products has a short interest ratio ("days to cover") of 5.8.
  • Change versus previous month

    Short interest in Utah Medical Products has recently increased by 298.84%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Utah Medical Products pays a meaningful dividend of 2.15%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Utah Medical Products has only been increasing its dividend for 3 years.

  • Dividend Coverage

    The dividend payout ratio of Utah Medical Products is 32.28%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Utah Medical Products' dividend.
  • Percentage of Shares Shorted

    12.61% of the float of Utah Medical Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Utah Medical Products has a short interest ratio ("days to cover") of 5.8.
  • Change versus previous month

    Short interest in Utah Medical Products has recently increased by 298.84%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Utah Medical Products has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Utah Medical Products this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Utah Medical Products insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.40% of the stock of Utah Medical Products is held by insiders.

  • Percentage Held by Institutions

    69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Utah Medical Products' insider trading history.
Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

UTMD Stock News Headlines

UTMD Utah Medical Products, Inc. - Seeking Alpha
Revolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial Underway
Tiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!
See More Headlines

UTMD Stock Analysis - Frequently Asked Questions

Utah Medical Products' stock was trading at $61.47 on January 1st, 2025. Since then, UTMD shares have decreased by 8.3% and is now trading at $56.3450.

Utah Medical Products, Inc. (NASDAQ:UTMD) announced its quarterly earnings data on Tuesday, April, 29th. The medical instruments supplier reported $0.92 earnings per share for the quarter. The medical instruments supplier earned $9.71 million during the quarter. Utah Medical Products had a trailing twelve-month return on equity of 10.74% and a net margin of 33.00%.

Top institutional shareholders of Utah Medical Products include Cardinal Capital Management (0.70%).
View institutional ownership trends
.

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Utah Medical Products investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
4/29/2025
Record date for 7/3 Dividend
6/16/2025
Ex-Dividend for 7/3 Dividend
6/16/2025
Dividend Payable
7/03/2025
Today
7/16/2025
Next Earnings (Estimated)
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:UTMD
CIK
706698
Employees
180
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$3.78
Trailing P/E Ratio
14.89
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$13.87 million
Net Margins
33.00%
Pretax Margin
40.39%
Return on Equity
10.74%
Return on Assets
10.27%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
22.29
Quick Ratio
20.29

Sales & Book Value

Annual Sales
$40.90 million
Price / Sales
4.47
Cash Flow
$4.89 per share
Price / Cash Flow
11.50
Book Value
$34.62 per share
Price / Book
1.63

Miscellaneous

Outstanding Shares
3,250,000
Free Float
3,008,000
Market Cap
$182.89 million
Optionable
Not Optionable
Beta
0.28

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:UTMD) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners